Abstract
A total of 374 sera, found by enzyme-linked immunosorbent assay (Rubazyme; Abbott Laboratories, North Chicago, Ill.) to have borderline rubella antibody levels, were tested by hemagglutination inhibition. All sera had Rubazyme indexes in the range of 0.500 to 1.499. Rubazyme sensitivity was 59.0%, and specificity was 80.8%. The predictive value of Rubazyme-positive result was 91.4%, and that for a negative result was 36.4%. Immune and nonimmune results were significantly different between the two methods (P less than 0.001). The same sera were retested with the Rubazyme test, with an inter-run agreement of 75.3%. A significant difference in Rubazyme indexes between runs (P less than 0.001) was observed. An alternative method of testing specimens in the range close to the Rubazyme index cutoff value of 1.000 may be indicated.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kleeman K. T., Kiefer D. J., Halbert S. P. Rubella antibodies detected by several commercial immunoassays in hemagglutination inhibition-negative sera. J Clin Microbiol. 1983 Nov;18(5):1131–1137. doi: 10.1128/jcm.18.5.1131-1137.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shekarchi I. C., Sever J. L., Tzan N., Ley A., Ward L. C., Madden D. Comparison of hemagglutination inhibition test and enzyme-linked immunosorbent assay for determining antibody to rubella virus. J Clin Microbiol. 1981 May;13(5):850–854. doi: 10.1128/jcm.13.5.850-854.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Truant A. L., Barksdale B. L., Huber T. W., Elliott L. B. Comparison of an enzyme-linked immunosorbent assay with indirect hemagglutination and hemagglutination inhibition for determination of rubella virus antibody: evaluation of immune status with commercial reagents in a clinical laboratory. J Clin Microbiol. 1983 Jan;17(1):106–108. doi: 10.1128/jcm.17.1.106-108.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]